Caribou Biosciences, Inc.CRBUNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-1171.23%
↓ 54% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-758.13%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -1171.23% | +28.1% |
| 2024 | -1627.87% | -398.7% |
| 2023 | -326.40% | +52.8% |
| 2022 | -691.00% | -1.1% |
| 2021 | -683.58% | -140.0% |
| 2020 | -284.82% | +45.4% |
| 2019 | -521.99% | - |